These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7705875)

  • 1. Interaction of pargyline with tolbutamide in rabbits.
    Satyanarayana S; Krishna DM; Krishnaiah YS; Visweswaram D
    Indian J Physiol Pharmacol; 1995 Jan; 39(1):71-3. PubMed ID: 7705875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isoniazid and rifampicin in the rabbit. Effect on hepatic microsomal enzyme activity].
    Kergueris MF; Larousse C; Le Normand Y; Guillerme G; Bourin M
    J Pharmacol; 1982; 13(4):525-34. PubMed ID: 7154665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man.
    Gachályi B; Tornyossy M; Vas A; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):133-5. PubMed ID: 6103880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of pargyline with rat hepatic microsomes.
    Valerino DM; Vesell ES; Stevens JT; Rudnick SL
    Pharmacology; 1978; 17(2):113-7. PubMed ID: 684076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of ranitidine on the hypoglycaemic activity of glibenclamide and tolbutamide in rabbits.
    Krishnaiah YS; Satyanarayana S; Visweswaram D
    Indian J Physiol Pharmacol; 1994 Oct; 38(4):316-8. PubMed ID: 7883304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The labeling in vivo of monoamine oxidase by 14 C-pargyline: a tool for studying the synthesis of the enzyme.
    Erwin VG; Deitrich RA
    Mol Pharmacol; 1971 Mar; 7(2):219-28. PubMed ID: 5125856
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers.
    Uchida S; Yamada H; Li XD; Maruyama S; Ohmori Y; Oki T; Watanabe H; Umegaki K; Ohashi K; Yamada S
    J Clin Pharmacol; 2006 Nov; 46(11):1290-8. PubMed ID: 17050793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short term anti-tubercular drug therapy and hepatic microsomal enzyme activity. Antipyrine metabolism as an index.
    Hamide A; Sivagnanam G; Raveendran R; Adithan C; Sivaraman V; Chandrasekar S
    J Assoc Physicians India; 1990 Sep; 38(9):631-2. PubMed ID: 2266077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenazone as a marker of liver-metabolic function in patients with acute leukemia.
    Wiela-Hojenska A; Orzechowska-Juzwenko K; Usnarska-Zubkiewicz L; Kotlarek-Haus S; Hurkacz M
    Int J Clin Pharmacol Ther; 1999 May; 37(5):234-7. PubMed ID: 10363621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of nitric oxide (NO) in hypoglycaemic activity of tolbutamide.
    Satyanarayana S; Krishnaiah YS; Rao BK
    Indian J Physiol Pharmacol; 1998 Oct; 42(4):551-4. PubMed ID: 10874360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (Ureyl- 14 C) tolbutamide and (2- 14 C) pentobarbitone as substrates for the hepatic microsomal drug-metabolizing enzyme system in vitro.
    Darby FJ; Evans DA
    J Physiol; 1971 Dec; 219(2):7P-8P. PubMed ID: 5158408
    [No Abstract]   [Full Text] [Related]  

  • 12. [In vivo activity of drug-metabolizing enzymes in various pathological conditions].
    Krakovskiĭ ME; Ashirmetov AKh
    Vopr Med Khim; 1985; 31(1):76-9. PubMed ID: 3984279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of age, sex and breed on antipyrine disposition in calves.
    Depelchin BO; Bloden S; Michaux C; Ansay M
    Res Vet Sci; 1988 Mar; 44(2):135-9. PubMed ID: 3387662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tolbutamide after oral administration in rabbits with folate-induced renal failure.
    Bae HY; Choi DH; Choi JS
    Res Commun Mol Pathol Pharmacol; 2002; 111(5-6):237-44. PubMed ID: 15244039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug interaction during therapy with tolbutamide. The influence of some commonly used drugs on plasma level and half life in diabetic out-patients (author's transl)].
    Kolenda KD; Grille W; Johnsen K
    Med Klin; 1979 Dec; 74(50):1914-22. PubMed ID: 542176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Griseofulvin-tolbutamide interaction.
    Iyer KS; Ummer A; Menon PN; Verghese Z
    Indian J Physiol Pharmacol; 1970 Oct; 14(4):293-6. PubMed ID: 5526136
    [No Abstract]   [Full Text] [Related]  

  • 17. Ginkgo biloba extract modifies hypoglycemic action of tolbutamide via hepatic cytochrome P450 mediated mechanism in aged rats.
    Sugiyama T; Kubota Y; Shinozuka K; Yamada S; Wu J; Umegaki K
    Life Sci; 2004 Jul; 75(9):1113-22. PubMed ID: 15207658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic factors influencing the metabolism of tolbutamide.
    Back DJ; Orme ML
    Pharmacol Ther; 1989; 44(2):147-55. PubMed ID: 2519343
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation of alcohol and tolbutamide blood clearance rates with microsomal alcohol-metabolizing enzyme activity.
    Kostelnik ME; Iber FL
    Am J Clin Nutr; 1973 Feb; 26(2):161-4. PubMed ID: 4145020
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of chlormethiazole on hepatic monooxygenases activity in vivo.
    Mönig H; Back DJ; Heidemann HT; Ohnhaus EE; Brockmann B; Schulte HM
    Eur J Clin Pharmacol; 1993; 44(2):203-4. PubMed ID: 8453968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.